Modern drug delivery to cancer patients involves the use of advanced technologies that aim to increase the effectiveness of treatment and reduce side effects. These technologies include nanoparticles, RNA-based technologies, and smart drug delivery systems that allow for precise targeting of cancer cells and drug delivery to them.

Nanoparticles: Nanoparticles act as drug carriers and can deliver drugs directly to cancer cells, preventing damage to healthy cells.

RNA-based technologies: RNAs play an important role in gene expression. RNA-based technologies such as siRNA and miRNA can inhibit the growth of cancer cells by targeting specific genes involved in tumor growth.

Smart drug delivery systems: These systems operate based on specific tumor characteristics, such as high pH or temperature, and release the drug only at the tumor site.

Benefits of modern drug delivery: Increased treatment effectiveness: Drugs reach cancer cells directly and have greater therapeutic effects.

Reduced side effects: Healthy cells are protected from the toxic effects of drugs.

Possibility of targeted therapy: Using modern technologies, it is possible to target specific cancer cells in the body and prevent their growth and spread.

Examples of applications of modern drug delivery: Production of targeted drugs: Drugs that specifically bind to cancer cells and destroy them.

Use of nanoparticles in the treatment of lung cancer: Nanoparticles can deliver drugs to cancer cells in the lung and prevent damage to surrounding healthy tissues.

Developing drugs that extend the life of cancer patients: Some new drugs developed using new technologies can significantly extend the life of cancer patients.

Challenges: High cost of production: New technologies are usually more expensive than traditional treatments.

Regulatory approval: These technologies require approval from regulatory agencies such as the US Food and Drug Administration (FDA) to be used in the treatment of patients.

Access to technology: Not all patients still have access to new technologies, which undermines equity in treatment.

Conclusion: New drug delivery in cancer treatment is a growing field that has great potential to improve treatment outcomes and quality of life for cancer patients. With continued research and development of new technologies, we can expect to see further advances in this field in the future.